PD-1, an inhibitory co-signaling molecule regarded as a marker for exhausted, poorly functional CD4+ and CD8+ T cells, often highly expressed in tumor infiltrating T lymphocytes, was also reduced in the peripheral CD4+and CD8+ T cells, suggesting improved immune response (Figure 4). The gene discussed is CD8A; the disease is neoplasm.